Company Filing History:
Years Active: 2018
Title: Sabina Koj: Innovator in Glycoconjugate Vaccines
Introduction
Sabina Koj is a notable inventor based in Dobrodzień, Poland. She has made significant contributions to the field of immunology through her innovative work on glycoconjugate vaccines. Her research focuses on developing non-toxic and immunogenic compounds that can enhance vaccine efficacy.
Latest Patents
Sabina Koj holds 1 patent related to an immunogenic and non-toxic glycoconjugate. This invention comprises LOS-derived oligosaccharides and pertussis toxin. The patent outlines a method for preparing the glycoconjugate, along with its pharmaceutical and vaccine compositions. The glycoconjugate is designed as a vaccine component to protect against infections.
Career Highlights
Sabina Koj is affiliated with Wroclawskie Centrum Badan Eit+ Sp. Z O.o., where she conducts her research. Her work has been instrumental in advancing the understanding of glycoconjugate applications in vaccines. She has demonstrated a commitment to improving public health through her innovative approaches.
Collaborations
Some of her notable coworkers include Tomasz Niedziela and Czeslaw Lugowski. Their collaborative efforts contribute to the success of the projects at Wroclawskie Centrum Badan Eit+ Sp. Z O.o.
Conclusion
Sabina Koj's contributions to glycoconjugate vaccines highlight her role as an innovator in the field of immunology. Her work not only advances scientific knowledge but also has the potential to impact public health positively.